Takeda

Takeda establishes new trading company and reinforces business structure in China

TakedaTakeda Pharmaceutical Company Limited ("Takeda") today announced the launch of a new trading company in China, Takeda (China) International Trading Co., Ltd. ("TCIT"), which will strengthen its business structure in China, and is an important step in the local integration of Nycomed following Takeda's acquisition of Nycomed completed in September 2011.

TCIT, which began operations in January 2013, will serve as a central hub for importing Takeda products from the Company's global manufacturing sites. To complete the integration with Nycomed in China, about 500 employees from Nycomed Pharmaceutical Consultancy (Shanghai) Co., Ltd. ("Nycomed Shanghai") are being transferred to TCIT and other Takeda China organizations. The liquidation of Nycomed Shanghai is planned to be completed by the end of March 2015.

"Takeda provides patients across China with a broad portfolio of products, which are adapted to local patient needs. Our new business structure will simplify our distribution processes and improve our efficiency to better serve patients in this huge and important market," said Haruhiko Hirate, Corporate Officer and Head of North Asia of Takeda. "In conjunction with the recent opening of our Development Center in Shanghai, we are now best equipped to bring new products to Chinese patients as early as possible."

China is Takeda's seventh largest market by revenue, and a cornerstone of Takeda's strategy to grow in emerging markets. Takeda entered the Chinese market in 1994, and established a strong footprint in China, which today includes sales and marketing, development and manufacturing. Most recently, the acquisition of Nycomed and the investment in the Takeda Shanghai Development Center further strengthened Takeda's commercial position as well as clinical development capabilities.

China is expected to be the largest market in Asia, and second largest globally by 2016. Takeda is outpacing the market growth in China, with the highest market share among Japanese pharmaceutical companies in the country. The Company aims to achieve top line growth of 29% CAGR between FY 2012-2016.

Further information about Takeda (China) International Trading Co., Ltd.:
This company will import finished products from Takeda global manufacturing sites and transfer them to Takeda Pharmaceutical (China) Company Limited, which is the distribution hub for all Takeda products. The current sales force and marketing team of Nycomed Shanghai now belong to this company. The profile of this company is as follows:

  • Establishment: September 2012 (capital paid in October 2012)
  • Start of operation: January 2013
  • Location: Shanghai Waigaoqiao Free Trade Zone
  • Capital Stock: 8.4 million USD

About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine.

Most Popular Now

World's first public dengue immuniz…

Sanofi and its vaccines global business unit Sanofi Pasteur announced today that the first public dengue immunization program has started in the Philippines. At a major l...

Read more

NIH launches large clinical trials …

Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection. Known as the A...

Read more

AstraZeneca and Eli Lilly and Compa…

AstraZeneca and Eli Lilly and Company today announced that AMARANTH, a Phase II/III study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in...

Read more

Saxenda® demonstrated significant i…

Today, new data from the three-year part of the phase 3a SCALE™ (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial were presented at th...

Read more

Vitamin D improves heart function, …

A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found. Dr Klaus Witte, from ...

Read more

Pfizer announces termination of pro…

Pfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The deci...

Read more

New analysis shows only minority of…

Boehringer Ingelheim has announced a new publication showing that levels of white blood cells called eosinophils can help identify patients with COPD who may and may not ...

Read more

Researchers open the way to new tre…

In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length struc...

Read more

Implantable device targets pancreat…

Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, whi...

Read more

Physicians' knowledge about FDA app…

Since 2012, the FDA can designate a drug as a "breakthrough therapy" if preliminary clinical evidence - such as an improvement in a pharmacodynamic biomarker - suggests a...

Read more

Global spending on health is expect…

Global inequities in health spending are expected to persist and intensify over the next 25 years, according to a new study that estimates total health financing in count...

Read more

Americans live longer but with disa…

Americans are living longer but in poorer health, according to a new study. The USC-led study examined life expectancy trends and disability rates in a 40-year period, fr...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]